title: Differential clinical outcome of dengue infection among patients with and without HIV infection: a matched case-control study.
abstract: Clinical characteristics and outcome among dengue patients with and without human immunodeficiency virus (HIV) infection remain elusive. A total of 10 dengue virus (DENV)-HIV Chinese patients were compared with 40 Chinese dengue patients without HIV, who were matched for age, gender, type of care received, methods, and year of dengue diagnosis from 2005 to 2008. Univariate and multivariate conditional logistics regression were applied. DENV-HIV patients were significantly associated with the World Health Organization (WHO) 2009 severe dengue (conditional odds ratio [COR] = 5.72; 95% confidence interval [CI] = 1.01-32.64) but not with the WHO 1997 dengue hemorrhagic fever/dengue shock syndrome (COR = 0.40; 95% CI = 0.09-1.71). This is mainly due to severe plasma leakage and the lack of hemorrhagic manifestations. Hospitalization duration was longer for DENV-HIV patients (10.5 days; interquartile range [IQR] = 5.5-26.3 days) compared with dengue patients (5 days; IQR = 4-6 days). There were no significant differences in presentation of clinical warning signs and symptoms at admission and during hospitalization, except for rash (adjusted COR [ACOR] = 0.06; 95% CI = 0.03-0.92). DENV-HIV patients were associated with higher pulse rate (ACOR = 1.13; 95% CI = 1.02-1.25), eosinophils proportion (ACOR = 3.07; 95% CI = 1.12-8.41) and lower hematocrit level (ACOR = 0.79; 95% CI = 0.64-0.98) compared with dengue patients. Even though DENV-HIV patients may present similarly to dengue patients, they may be more likely to have severe dengue outcome. Hence, close monitoring of DENV-HIV patients is highly recommended as part of dengue clinical care and management.
authors.forename: Junxiong
authors.initials: J
authors.lastname: Pang
authors.forename: Tun-Linn
authors.initials: TL
authors.lastname: Thein
authors.forename: David C
authors.initials: DC
authors.lastname: Lye
authors.forename: Yee-Sin
authors.initials: YS
authors.lastname: Leo
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D060085:Coinfection / Q000473:pathology / Q000821:virology*; D003715:Dengue / Q000150:complications* / Q000473:pathology / Q000821:virology; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000473:pathology / Q000821:virology; D006801:Humans; D008297:Male; D008875:Middle Aged; D063868:Patient Outcome Assessment
references.citation: Lancet. 2000 Aug 5;356(9228):475-9
references.pmid: 10981892
references.citation: Am J Trop Med Hyg. 2012 Apr;86(4):720-3
references.pmid: 22492160
references.citation: N Engl J Med. 2001 Sep 6;345(10):715-24
references.pmid: 11547740
references.citation: Clin Infect Dis. 2002 May 1;34(9):1264-6
references.pmid: 11941554
references.citation: Clin Infect Dis. 2003 Apr 15;36(8):1067-9
references.pmid: 12684921
references.citation: AIDS Educ Prev. 2004 Jun;16(3 Suppl A):110-8
references.pmid: 15262570
references.citation: Infect Immun. 1980 May;28(2):428-33
references.pmid: 6967450
references.citation: Am J Trop Med Hyg. 1994 Mar;50(3):261-8
references.pmid: 8147485
references.citation: Immunol Today. 1994 Oct;15(10):498-9
references.pmid: 7945779
references.citation: PLoS Negl Trop Dis. 2012;6(5):e1641
references.pmid: 22563519
references.citation: Malar J. 2012;11:142
references.pmid: 22549018
references.citation: Int J STD AIDS. 2012 Sep;23(9):635-8
references.pmid: 23033516
references.citation: PLoS One. 2013;8(3):e60206
references.pmid: 23555926
references.citation: PLoS One. 2013;8(4):e60946
references.pmid: 23573291
references.citation: Am J Trop Med Hyg. 2013 Oct;89(4):804-10
references.pmid: 23980129
references.citation: Int J Infect Dis. 2014 Jan;18:41-6
references.pmid: 24183717
references.citation: PLoS Negl Trop Dis. 2014 Oct;8(10):e3239
references.pmid: 25340346
references.citation: BMC Infect Dis. 2014;14:649
references.pmid: 25475217
references.citation: Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:246-9
references.pmid: 7886587
references.citation: J Infect Dis. 1996 Sep;174(3):615-8
references.pmid: 8769622
references.citation: Clin Microbiol Rev. 1997 Apr;10(2):298-319
references.pmid: 9105756
references.citation: J Infect Dis. 1997 May;175(5):1283
references.pmid: 9129106
references.citation: J Infect Dis. 1997 Sep;176(3):766-70
references.pmid: 9291329
references.citation: J Infect Dis. 1998 Dec;178(6):1642-8
references.pmid: 9815216
references.citation: AIDS. 1999 Mar 11;13(4):487-94
references.pmid: 10197377
references.citation: Am J Trop Med Hyg. 2006 May;74(5):905-7
references.pmid: 16687700
references.citation: Emerg Infect Dis. 2006 Jun;12(6):887-93
references.pmid: 16707042
references.citation: Ann Acad Med Singapore. 2006 Apr;35(4):229-35
references.pmid: 16710492
references.citation: Lancet. 2006 Aug 5;368(9534):489-504
references.pmid: 16890836
references.citation: Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15570-5
references.pmid: 17030806
references.citation: Int J Infect Dis. 2007 May;11(3):263-7
references.pmid: 16899384
references.citation: Southeast Asian J Trop Med Public Health. 2008 Mar;39(2):260-5
references.pmid: 18564711
references.citation: J Infect Dis. 2008 Sep 15;198(6):860-3
references.pmid: 18721058
references.citation: Pediatr Infect Dis J. 2009 Jan;28(1):63-5
references.pmid: 19057456
references.citation: Neurology. 2009 Jan 20;72(3):289-90
references.pmid: 19153378
references.citation: J Infect Dev Ctries. 2009;3(4):318-20
references.pmid: 19759497
references.citation: J Immunol. 2009 Dec 15;183(12):7860-9
references.pmid: 19923460
references.citation: Emerg Infect Dis. 2010 May;16(5):847-9
references.pmid: 20409381
references.citation: Lancet. 2011 Jan 15;377(9761):252-69
references.pmid: 21227500
references.citation: Lancet. 2011 Feb 12;377(9765):599-609
references.pmid: 21269678
references.citation: N Engl J Med. 2001 Sep 6;345(10):707-14
references.pmid: 11547739